Rivaroxaban and hemostasis in emergency care. - Wikidata - wikimedia - TriplyDB

Rivaroxaban and hemostasis in emergency care.

Rivaroxaban and hemostasis in emergency care.

http://www.wikidata.org/entity/Q37631564

about

Use of rivaroxaban in patients with stroke.Bleeding associated with coadministration of rivaroxaban and clarithromycin.Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings.

P2860

Q38941684-6E5B0754-72BD-465A-9FF4-B443EA2AA513 Q42154770-8D598F31-05EC-4E8D-BC6C-C8356EFA3D9F Q47161289-655FD46D-3A90-43D6-9767-1273D4C6A810

P2860

Rivaroxaban and hemostasis in emergency care.

http://www.wikidata.org/entity/Q37631564

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Rivaroxaban and hemostasis in emergency care.

@en

Rivaroxaban and hemostasis in emergency care.

@nl

type

label

Rivaroxaban and hemostasis in emergency care.

@en

Rivaroxaban and hemostasis in emergency care.

@nl

prefLabel

Rivaroxaban and hemostasis in emergency care.

@en

Rivaroxaban and hemostasis in emergency care.

@nl

P1433

Q37631564-0161C6F7-6B6A-4291-9BC9-E4C180852D6E

P1476

Q37631564-C4FABAD8-3680-41AE-B410-80FCDB2858E5

P2093

Q37631564-1F149544-39FD-42C8-8EAD-D5AA1792F108

Q37631564-C4B30EBA-F4C7-460D-8DC7-8D9A1BD241AD

P2860

Q37631564-11555FF5-45EA-4DBC-97C6-F5F88704AEA3

Q37631564-200BB419-5336-4331-84ED-FA413DB3ACA7

Q37631564-34EDAFA4-F90B-470C-AACC-9F47AE859254

Q37631564-390E59CE-63B0-4803-BF77-194704797916

Q37631564-3BF7BB04-C74C-4855-975C-77D0F0DC22E1

Q37631564-3C0F12E2-E69F-4FB9-9A6F-9AC191646F16

Q37631564-3D09D73F-BDFC-4ACA-B1D2-2F48AFB04121

Q37631564-47F0EDCE-FF74-4BC0-A7EC-EA8387D4F1F7

Q37631564-51A94256-4D44-46F0-B73D-F8E47DFFC9EE

Q37631564-5A0F80D2-EB3B-4C93-AFE4-1A3C33AC7BB4

P304

Q37631564-0AF5D96A-4A39-4BEB-B738-5E4D8CE4EF7C

P31

Q37631564-DBDD0656-89EA-491D-A32E-E765CB7D7E81

P356

Q37631564-62F507D4-6D0B-4203-A6EC-6F828FADDF8E

P478

Q37631564-BAF012C5-4D98-41C7-8456-80D1082D5041

P577

Q37631564-DCFB6E0F-A2BA-49F4-A91B-F8E51ED3B026

P5875

Q37631564-C80FB7C1-011A-485D-AB2D-DD272D22F261

P698

Q37631564-C4CDDC50-46A8-4A1F-A1C8-D70EE7D97967

P932

Q37631564-84CEA636-8E5D-4204-A034-F1A33A63E52C

P356

P1433

Emergency Medicine International

P1476

Rivaroxaban and hemostasis in emergency care.

@en

P2093

Edita Rutkauskaite

http://www.w3.org/2001/XMLSchema#string

Jürgen Koscielny

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Oral rivaroxaban for symptomatic venous thromboembolism

Rivaroxaban in patients with a recent acute coronary syndrome.

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor

Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor.

Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity.

An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies

P304

935474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/935474

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261329248

http://www.w3.org/2001/XMLSchema#string

P698

24696784

http://www.w3.org/2001/XMLSchema#string

P932

3950542

http://www.w3.org/2001/XMLSchema#string